[시장보고서]세계의 예측 독성학용 AI 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2025-2033년)

세계의 예측 독성학용 AI 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2025-2033년)

Global AI In Predictive Toxicology Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

상품코드 : 1820533

리서치사 : Value Market Research

발행일 : 2025년 08월

페이지 정보 : 영문 149 Pages

라이선스 & 가격 (부가세 별도)

US $ 3,920

￦ 5,838,000

PDF & Excel (Single User License)

PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 전자파일의 이용 범위와 동일합니다.

US $ 4,730

￦ 7,044,000

PDF & Excel (10-user License)

PDF 및 Excel 보고서를 동일 기업 내 10명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 전자파일의 이용 범위와 동일합니다.

US $ 7,430

￦ 11,065,000

PDF & Excel (Corporate User License)

PDF 및 Excel 보고서를 동일 기업 내 모든 사용자가 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 전자파일의 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

세계의 예측 독성학용 AI 시장은 대폭적인 성장을 이루면서 2024년 5억 달러에서 2033년에는 53억 7,000만 달러에 이를 것으로 예측됩니다. 이 시장은 2025-2033년 30.04%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다.

머신러닝 알고리즘과 빅데이터 분석이 독성 평가의 정확성과 속도를 향상시킴에 따라 예측 독성학 분야의 AI 시장은 빠르게 변화하고 있습니다. 방대한 화학적, 생물학적 데이터 세트를 활용함으로써 AI 모델은 독성학적 위험을 조기에 식별하고 동물 실험에 대한 의존도를 낮추며 의약품 개발 파이프라인을 가속화할 수 있습니다. 딥러닝 기술과 인실리콘 모델링의 통합으로 유전독성 및 면역독성을 포함한 복잡한 독성 평가변수 예측이 전례 없는 정확도로 쉬워지고 있습니다. 이러한 기술 발전은 의약품, 화학물질, 소비자 제품 전반에 걸친 규제 준수 및 안전성 평가에 필수적입니다.

또한, AI와 하이스루풋 스크리닝 및 오믹스 기술의 융합으로 예측 모델을 개선하고 독성 경로의 메커니즘 이해를 지원하는 다차원 데이터 세트가 생성되고 있습니다. 클라우드 기반 플랫폼과 공동 데이터 공유 이니셔티브는 AI 도구에 대한 접근을 민주화하고 독성 평가의 혁신과 표준화를 촉진하고 있습니다. 규제 당국이 AI를 활용한 방법을 점점 더 많이 권장함에 따라, 시장은 더욱 안전한 제품 개발과 새로운 화합물 시장 출시 시간 단축을 촉진할 수 있는 가속화된 시장으로 발전할 준비가 되어 있습니다.

지역별 전망
서론
북미의 판매 분석
- 개요, 분석과 예측
- 북미 : 부문별
- 북미 국가별
- 미국
- 캐나다
- 멕시코
유럽의 판매 분석
- 개요, 분석과 예측
- 유럽 : 부문별
- 유럽 국가별
- 영국
- 프랑스
- 독일
- 이탈리아
- 러시아
- 기타 유럽
아시아태평양의 판매 분석
- 개요, 분석과 예측
- 아시아태평양 : 부문별
- 아시아태평양 국가별
- 중국
- 인도
- 일본
- 한국
- 호주
- 동남아시아
- 기타 아시아태평양
라틴아메리카의 판매 분석
- 개요, 분석과 예측
- 라틴아메리카 : 부문별
- 라틴아메리카 국가별
- 브라질
- 아르헨티나
- 페루
- 칠레
- 기타 라틴아메리카
중동 및 아프리카의 판매 분석
- 개요, 분석과 예측
- 중동 및 아프리카 : 부문별
- 중동 및 아프리카 국가별 리스트
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 남아프리카공화국
- 기타 중동 및 아프리카

제10장 예측 독성학용 AI기업 경쟁 구도

예측 독성학용 AI 시장 경쟁
제휴, 협력 및 합의
인수합병(M&A)
신제품 출시
기타 개발

제11장 기업 개요

주요 기업의 시장 점유율 분석
시장 집중도
Benevolent AI
Berg Health
Biovista
Celsius Therapeutics
Chemaxon Ltd.
Cyclica
Exscientia PLC
Insilico Medicine
Instem Plc
Lhasa Limited
Recursion Pharmaceuticals

LSH

영문 목차

영문목차

Global AI In Predictive Toxicology Market is poised to witness substantial growth, reaching a value of USD 5.37 Billion by the year 2033, up from USD 0.5 Billion attained in 2024. The market is anticipated to display a Compound Annual Growth Rate (CAGR) of 30.04% between 2025 and 2033.

The AI in predictive toxicology market is undergoing rapid transformation as machine learning algorithms and big data analytics enhance the accuracy and speed of toxicity assessments. By leveraging vast chemical and biological datasets, AI models are enabling early identification of toxicological risks, reducing reliance on animal testing and expediting drug development pipelines. The integration of deep learning techniques with in silico modeling is facilitating the prediction of complex toxicological endpoints, including genotoxicity and immunotoxicity, with unprecedented precision. This technological advancement is critical for regulatory compliance and safety evaluation across pharmaceuticals, chemicals, and consumer products.

Furthermore, the convergence of AI with high-throughput screening and omics technologies is generating multidimensional datasets that refine predictive models and support mechanistic understanding of toxicity pathways. Cloud-based platforms and collaborative data-sharing initiatives are democratizing access to AI tools, fostering innovation and standardization in toxicology assessments. As regulatory agencies increasingly endorse AI-driven methodologies, the market is poised for accelerated adoption, driving safer product development and reducing time-to-market for novel compounds.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

LIST OF SEGMENTS COVERED

This section of the AI In Predictive Toxicology market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Component

Solution
Services

By Technology

Machine Learning
Natural Language Processing
Computer Vision
Others

By Toxicity Endpoints

Genotoxicity
Hepatotoxicity
Neurotoxicity
Cardiotoxicity
Others

By End User

Pharmaceutical & Biotechnology Companies
Chemical & Cosmetics
Contract Research Organizations
Others
List of Companies Profiled in the report
Benevolent AI, Berg Health, Biovista, Celsius Therapeutics, Chemaxon Ltd., Cyclica, Exscientia PLC, Insilico Medicine, Instem plc, Lhasa Limited, Recursion Pharmaceuticals.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. AI IN PREDICTIVE TOXICOLOGY - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Component
- 3.7.2 Market Attractiveness Analysis By Technology
- 3.7.3 Market Attractiveness Analysis By Toxicity Endpoints
- 3.7.4 Market Attractiveness Analysis By End User
- 3.7.5 Market Attractiveness Analysis By Regions

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL AI IN PREDICTIVE TOXICOLOGY MARKET ANALYSIS BY COMPONENT

5.1. Overview By Component
5.2. Historical and Forecast Data Analysis By Component
5.3. Solution Historic and Forecast Sales By Regions
5.4. Services Historic and Forecast Sales By Regions

6. GLOBAL AI IN PREDICTIVE TOXICOLOGY MARKET ANALYSIS BY TECHNOLOGY

6.1. Overview By Technology
6.2. Historical and Forecast Data Analysis By Technology
6.3. Machine Learning Historic and Forecast Sales By Regions
6.4. Natural Language Processing Historic and Forecast Sales By Regions
6.5. Computer Vision Historic and Forecast Sales By Regions
6.6. Others Historic and Forecast Sales By Regions

7. GLOBAL AI IN PREDICTIVE TOXICOLOGY MARKET ANALYSIS BY TOXICITY ENDPOINTS

7.1. Overview By Toxicity Endpoints
7.2. Historical and Forecast Data Analysis By Toxicity Endpoints
7.3. Genotoxicity Historic and Forecast Sales By Regions
7.4. Hepatotoxicity Historic and Forecast Sales By Regions
7.5. Neurotoxicity Historic and Forecast Sales By Regions
7.6. Cardiotoxicity Historic and Forecast Sales By Regions
7.7. Others Historic and Forecast Sales By Regions

8. GLOBAL AI IN PREDICTIVE TOXICOLOGY MARKET ANALYSIS BY END USER

8.1. Overview By End User
8.2. Historical and Forecast Data Analysis By End User
8.3. Pharmaceutical & Biotechnology Companies Historic and Forecast Sales By Regions
8.4. Chemical & Cosmetics Historic and Forecast Sales By Regions
8.5. Contract Research Organizations Historic and Forecast Sales By Regions
8.6. Others Historic and Forecast Sales By Regions

9. GLOBAL AI IN PREDICTIVE TOXICOLOGY MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1 Overview, Historic and Forecast Data Sales Analysis
- 9.3.2 North America By Segment Sales Analysis
- 9.3.3 North America By Country Sales Analysis
- 9.3.4 United States Sales Analysis
- 9.3.5 Canada Sales Analysis
- 9.3.6 Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1 Overview, Historic and Forecast Data Sales Analysis
- 9.4.2 Europe By Segment Sales Analysis
- 9.4.3 Europe By Country Sales Analysis
- 9.4.4 United Kingdom Sales Analysis
- 9.4.5 France Sales Analysis
- 9.4.6 Germany Sales Analysis
- 9.4.7 Italy Sales Analysis
- 9.4.8 Russia Sales Analysis
- 9.4.9 Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1 Overview, Historic and Forecast Data Sales Analysis
- 9.5.2 Asia Pacific By Segment Sales Analysis
- 9.5.3 Asia Pacific By Country Sales Analysis
- 9.5.4 China Sales Analysis
- 9.5.5 India Sales Analysis
- 9.5.6 Japan Sales Analysis
- 9.5.7 South Korea Sales Analysis
- 9.5.8 Australia Sales Analysis
- 9.5.9 South East Asia Sales Analysis
- 9.5.10 Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1 Overview, Historic and Forecast Data Sales Analysis
- 9.6.2 Latin America By Segment Sales Analysis
- 9.6.3 Latin America By Country Sales Analysis
- 9.6.4 Brazil Sales Analysis
- 9.6.5 Argentina Sales Analysis
- 9.6.6 Peru Sales Analysis
- 9.6.7 Chile Sales Analysis
- 9.6.8 Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1 Overview, Historic and Forecast Data Sales Analysis
- 9.7.2 Middle East & Africa By Segment Sales Analysis
- 9.7.3 Middle East & Africa By Country Sales Analysis
- 9.7.4 Saudi Arabia Sales Analysis
- 9.7.5 UAE Sales Analysis
- 9.7.6 Israel Sales Analysis
- 9.7.7 South Africa Sales Analysis
- 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE AI IN PREDICTIVE TOXICOLOGY COMPANIES

10.1. AI In Predictive Toxicology Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11. COMPANY PROFILES OF AI IN PREDICTIVE TOXICOLOGY INDUSTRY

11.1. Top Companies Market Share Analysis
11.2. Market Concentration Rate
11.3. Benevolent AI
- 11.3.1 Company Overview
- 11.3.2 Company Revenue
- 11.3.3 Products
- 11.3.4 Recent Developments
11.4. Berg Health
- 11.4.1 Company Overview
- 11.4.2 Company Revenue
- 11.4.3 Products
- 11.4.4 Recent Developments
11.5. Biovista
- 11.5.1 Company Overview
- 11.5.2 Company Revenue
- 11.5.3 Products
- 11.5.4 Recent Developments
11.6. Celsius Therapeutics
- 11.6.1 Company Overview
- 11.6.2 Company Revenue
- 11.6.3 Products
- 11.6.4 Recent Developments
11.7. Chemaxon Ltd.
- 11.7.1 Company Overview
- 11.7.2 Company Revenue
- 11.7.3 Products
- 11.7.4 Recent Developments
11.8. Cyclica
- 11.8.1 Company Overview
- 11.8.2 Company Revenue
- 11.8.3 Products
- 11.8.4 Recent Developments
11.9. Exscientia PLC
- 11.9.1 Company Overview
- 11.9.2 Company Revenue
- 11.9.3 Products
- 11.9.4 Recent Developments
11.10. Insilico Medicine
- 11.10.1 Company Overview
- 11.10.2 Company Revenue
- 11.10.3 Products
- 11.10.4 Recent Developments
11.11. Instem Plc
- 11.11.1 Company Overview
- 11.11.2 Company Revenue
- 11.11.3 Products
- 11.11.4 Recent Developments
11.12. Lhasa Limited
- 11.12.1 Company Overview
- 11.12.2 Company Revenue
- 11.12.3 Products
- 11.12.4 Recent Developments
11.13. Recursion Pharmaceuticals
- 11.13.1 Company Overview
- 11.13.2 Company Revenue
- 11.13.3 Products
- 11.13.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of privcompanies

한글목차

목차

제1장 서문

제2장 주요 요약

제3장 예측 독성학용 AI- 산업 분석

제4장 밸류체인 분석

제5장 세계의 예측 독성학용 AI 시장 분석 : 컴포넌트별

제6장 세계의 예측 독성학용 AI 시장 분석 : 기술별

제7장 세계의 예측 독성학용 AI 시장 분석 : 독성 엔드포인트별

제8장 세계의 예측 독성학용 AI 시장 분석 : 최종사용자별

제9장 세계의 예측 독성학용 AI 시장 분석 : 지역별